Login / Signup

Economic impact of using maternal plasma cell-free DNA testing to guide further workup in recurrent pregnancy loss.

Siyang PengSucheta BhattAntoni BorrellYuval Yaron
Published in: Prenatal diagnosis (2021)
Our study showed that inclusion of cfDNA testing is a cost-effective approach to guide RPL workup.
Keyphrases
  • pregnancy outcomes
  • preterm birth
  • birth weight
  • body mass index